|
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
RECRUITINGPhase 4Sponsored by Janssen Research & Development, LLC
Actively Recruiting
PhasePhase 4
SponsorJanssen Research & Development, LLC
Started2022-03-09
Est. completion2037-07-29
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations28 sites
View on ClinicalTrials.gov →
NCT05201781
Summary
The purpose of this study is to collect long-term follow-up data on delayed adverse events after administration of ciltacabtagene autoleucel (cilta-cel), and to characterize and understand the long-term safety profile of cilta-cel.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Participants who have received at least one dose of cilta-cel in a Company-sponsored clinical study * Participants who have provided informed consent for this study
Conditions2
CancerMultiple Myeloma
Interventions1
Locations28 sites
City of Hope
University of California San Francisco
Stanford University Medical Center
Find trials near these locations
Cancer trials in PhoenixCancer trials in San FranciscoCancer trials in TampaCancer trials in AtlantaCancer trials in ChicagoCancer trials in IndianapolisCancer trials in BostonCancer trials in New YorkCancer trials in CharlotteCancer trials in PhiladelphiaCancer trials in NashvilleCancer trials in HoustonAll trials in ArizonaAll trials in CaliforniaAll trials in FloridaAll trials in GeorgiaAll trials in IllinoisAll trials in IndianaAll trials in MassachusettsAll trials in MinnesotaAll trials in MissouriAll trials in New YorkAll trials in North CarolinaAll trials in PennsylvaniaAll trials in TennesseeAll trials in TexasAll trials in Wisconsin
Related trials
- A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel — Janssen Research & Development, LLC
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 4
SponsorJanssen Research & Development, LLC
Started2022-03-09
Est. completion2037-07-29
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations28 sites
View on ClinicalTrials.gov →
NCT05201781